Generic Drugmakers to Sell Pfizer's Paxlovid US$ 25 or Less in Low-income Countries

KONTAN.CO.ID - NEW YORK. Several generic drugmakers that will produce versions of Pfizer's Covid-19 antiviral treatment Paxlovid have agreed to sell the medicine in low- and middle-income countries for US$ 25 a course or less. The Clinton Health Access Initiative (CHAI) said on Thursday.
CHAI said it could not disclose the names of the manufacturers who have agreed to the price ceiling. Because, they are still in the early stage of product development and have not received regulatory approval.
Ini Artikel Spesial
Agar bisa lanjut membaca sampai tuntas artikel ini, pastikan Anda sudah berlangganan.
Sudah berlangganan? MasukBerlangganan dengan Google
Gratis uji coba 7 hari pertama. Anda dapat menggunakan akun Google sebagai metode pembayaran.
Kontan Digital Premium Access
Business Insight, Epaper Harian + Tabloid, Arsip Epaper 30 Hari
Rp 120.000
Business Insight
Hanya dengan 20rb/bulan Anda bisa mendapatkan berita serta analisis ekonomi bisnis dan investasi pilihan